These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9209939)
1. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Parada H; Carrasco HA; Añez N; Fuenmayor C; Inglessis I Int J Cardiol; 1997 Jun; 60(1):49-54. PubMed ID: 9209939 [TBL] [Abstract][Full Text] [Related]
2. Cardiac Evaluation in the Acute Phase of Chagas' Disease with Post-Treatment Evolution in Patients Attended in the State of Amazonas, Brazil. Ortiz JV; Pereira BVM; Couceiro KDN; Silva MRHDSE; Doria SS; Silva PRLD; Lira EDF; Guerra MDGVB; Guerra JAO; Ferreira JMBB Arq Bras Cardiol; 2019 Mar; 112(3):240-246. PubMed ID: 30916205 [TBL] [Abstract][Full Text] [Related]
3. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs. Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285 [TBL] [Abstract][Full Text] [Related]
7. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Bellotti G; Bocchi EA; de Moraes AV; Higuchi M L; Barbero-Marcial M; Sosa E; Esteves-Filho A; Kalil R; Weiss R; Jatene A; Pileggi F Am Heart J; 1996 Feb; 131(2):301-7. PubMed ID: 8579025 [TBL] [Abstract][Full Text] [Related]
9. Chagas cardiomyopathy: The potential effect of benznidazole treatment on diastolic dysfunction and cardiac damage in dogs chronically infected with Trypanosoma cruzi. Santos FM; Mazzeti AL; Caldas S; Gonçalves KR; Lima WG; Torres RM; Bahia MT Acta Trop; 2016 Sep; 161():44-54. PubMed ID: 27215760 [TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of the Chagas' heart disease. Punukollu G; Gowda RM; Khan IA; Navarro VS; Vasavada BC Int J Cardiol; 2007 Feb; 115(3):279-83. PubMed ID: 16769134 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903 [TBL] [Abstract][Full Text] [Related]
12. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Souza FF; Castro-E-Silva O; Marin Neto JA; Sankarankutty AK; Teixeira AC; Martinelli AL; Gaspar GG; Melo L; Figueiredo JF; Romano MM; Maciel BC; Passos AD; Rossi MA Transplant Proc; 2008 Apr; 40(3):875-8. PubMed ID: 18455041 [TBL] [Abstract][Full Text] [Related]
13. [Fatal evolution of Chagas'disease/Aids co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy]. Almeida EA; Silva EL; Guariento ME; Souza ML; Aoki FH; Pedro Rde J Rev Soc Bras Med Trop; 2009; 42(2):199-202. PubMed ID: 19448942 [TBL] [Abstract][Full Text] [Related]
14. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. Fuenmayor C; Higuchi ML; Carrasco H; Parada H; Gutierrez P; Aiello V; Palomino S Acta Cardiol; 2005 Feb; 60(1):33-7. PubMed ID: 15779849 [TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal therapy for chronic Chagas' disease. Bern C N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649 [No Abstract] [Full Text] [Related]
17. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease. Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138 [TBL] [Abstract][Full Text] [Related]
18. Absence of left ventricular dysfunction during acute chagasic myocarditis in the rhesus monkey. Lima JA; Szarfman A; Lima SD; Adams RJ; Russell RJ; Cheever A; Trischmann T; Weiss JL Circulation; 1986 Jan; 73(1):172-9. PubMed ID: 3940666 [TBL] [Abstract][Full Text] [Related]
19. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588 [TBL] [Abstract][Full Text] [Related]
20. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Marin-Neto JA; Rassi A; Morillo CA; Avezum A; Connolly SJ; Sosa-Estani S; Rosas F; Yusuf S; Am Heart J; 2008 Jul; 156(1):37-43. PubMed ID: 18585495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]